Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy
Rishi Singh,1 Louis Alpern,2 Glenn J Jaffe,3 Robert P Lehmann,4 John Lim,5 Harvey J Reiser,6 Kenneth Sall,7 Thomas Walters,8 Dana Sager91Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, 2The Cataract, Glaucoma, and Refractive Surgery Center, El Paso, TX, 3Duke Eye Center, Duke Reading...
Saved in:
| Main Authors: | Singh R, Alpern L, Jaffe GJ, Lehmann RP, Lim J, Reiser HJ, Sall K, Walters T, Sager D |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2012
|
| Subjects: | |
| Online Access: | https://doaj.org/article/68e55cef097947b2af6c0e2cb449dc7a |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives
by: Yüksel B, et al.
Published: (2017) -
Topical nepafenac in the treatment of diabetic macular edema
by: David Callanan, et al.
Published: (2008) -
Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies
by: Singh RP, et al.
Published: (2017) -
Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
by: Seenu M Hariprasad, et al.
Published: (2009) -
Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema
by: Giarmoukakis AK, et al.
Published: (2020)